Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer

H Zhang, C Qin, C An, X Zheng, S Wen, W Chen, X Liu… - Molecular cancer, 2021 - Springer
Abstract The 2020 Nobel Prize in Chemistry was awarded to Emmanuelle Charpentier and
Jennifer Doudna for the development of the Clustered regularly interspaced short …

CRISPR technologies for genome, epigenome and transcriptome editing

L Villiger, J Joung, L Koblan, J Weissman… - … Reviews Molecular Cell …, 2024 - nature.com
Our ability to edit genomes lags behind our capacity to sequence them, but the growing
understanding of CRISPR biology and its application to genome, epigenome and …

Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases

T Wan, J Zhong, Q Pan, T Zhou, Y Ping, X Liu - Science advances, 2022 - science.org
CRISPR-Cas9 gene editing has emerged as a powerful therapeutic technology, but the lack
of safe and efficient in vivo delivery systems, especially for tissue-specific vectors, limits its …

Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing

Z Iqbal, K Rehman, J Xia, M Shabbir, M Zaman… - Biomaterials …, 2023 - pubs.rsc.org
RISPR-Cas9 has exhibited enormous potential in gene therapy. It can perform genome
editing with single-nucleotide precision in various types of cell and tissue, providing a …

Advanced nanotheranostics of CRISPR/Cas for viral hepatitis and hepatocellular carcinoma

H Kong, E Ju, K Yi, W Xu, YH Lao, D Cheng… - Advanced …, 2021 - Wiley Online Library
Liver disease, particularly viral hepatitis and hepatocellular carcinoma (HCC), is a global
healthcare burden and leads to more than 2 million deaths per year worldwide. Despite …

Engineered nanomaterials to potentiate CRISPR/Cas9 gene editing for cancer therapy

K Yi, H Kong, YH Lao, D Li, RL Mintz, T Fang… - Advanced …, 2024 - Wiley Online Library
Clustered regularly interspaced short palindromic repeats/associated protein 9
(CRISPR/Cas9) gene‐editing technology shows promise for manipulating single or multiple …

Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis

Y Hu, Y Xu, RL Mintz, X Luo, Y Fang, YH Lao, HF Chan… - Biomaterials, 2023 - Elsevier
Tumor-positive resection margins after surgery can result in tumor recurrence and
metastasis. Although adjuvant postoperative radiotherapy and chemotherapy have been …

Nanobiomaterial vectors for improving gene editing and gene therapy

SW Hu, T Ding, H Tang, H Guo, W Cui, Y Shu - Materials Today, 2023 - Elsevier
With the development of genome editing techniques, gene therapy is becoming a viable
option for the treatment of a variety of human diseases. Genome editing techniques mainly …

CRISPRimmunity: an interactive web server for CRISPR-associated Important Molecular events and Modulators Used in geNome edIting Tool identifYing

F Zhou, X Yu, R Gan, K Ren, C Chen… - Nucleic acids …, 2023 - academic.oup.com
The CRISPR-Cas system is a highly adaptive and RNA-guided immune system found in
bacteria and archaea, which has applications as a genome editing tool and is a valuable …

3D printed hydrogel scaffolds combining glutathione depletion-induced ferroptosis and photothermia-augmented chemodynamic therapy for efficiently inhibiting …

W Dang, WC Chen, E Ju, Y Xu, K Li, H Wang… - Journal of …, 2022 - Springer
Surgical resection to achieve tumor-free margins represents a difficult clinical scenario for
patients with hepatocellular carcinoma. While post-surgical treatments such as …